Immix Biopharma, Inc. IMMX Common Stock Shares Authorized
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s common stock shares authorized.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s common stock shares authorized?
- Immix Biopharma, Inc. (IMMX) reported common stock shares authorized of 5.3M in Q1 2026.
- How has Immix Biopharma, Inc.'s common stock shares authorized changed year-over-year?
- Immix Biopharma, Inc.'s common stock shares authorized increased by 30.4% year-over-year, from 4.1M to 5.3M.
- What is the long-term trend for Immix Biopharma, Inc.'s common stock shares authorized?
- Over 4 years (2021 to 2025), Immix Biopharma, Inc.'s common stock shares authorized has grown at a 41.3% compound annual growth rate (CAGR), from 1.3M to 5.3M.
- What does common stock shares authorized mean?
- This represents the maximum number of common stock shares that the company is legally permitted to issue under its corporate charter. It defines the upper limit of potential equity dilution and provides context for the company's capacity to raise future capital.